Adcytherix
Novel antibody drug conjugates (ADC) biopharmaceutical company, Marseille, France.
France · $154.2M raised
- Business Model
- B2B
- Website
- adcytherix.com
- Total Funding
- $154.2M
- Last Round
- $122.0M Series AOct 2025
- Rounds
- 2
About
Biopharmaceutical company developing novel proprietary antibody-drug conjugates (ADCs) for high unmet need diseases.
Summary
Adcytherix is a Biotech company based in France. It has raised $154.2M in total across 2 rounds, most recently a $122.0M Series A round in Oct 2025. Investors include Bpifrance, Kurma Partners and Andera Partners.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...